BioWorld MedTech

Jan. 26, 2016

Funding to Help with Clinical Trials: Jan Medical receives $7.5M from Brainlab in series C funding round

Jan Medical (Mountain View, Calif.), a private company, has scored $7.5 million in series C funding, to help navigate its Brainpulse technology through the regulatory path. Read More

Inside the Beltway: FDA releases draft guidance for medical device interoperability

Case not claimed by plaintiffs: SCOTUS: Ninth Circuit wrong again in Amgen shareholder case

Trend to Lower Risk Patients: TAVI surpasses heart valve surgery in Germany with 'astonishing adoption'

Rates raised to 7.5 percent on certain products: Indian customs duties raised in bid to promote local manufacturing

Daily M&A: Select to acquire Physiotherapy Associates for $400 million

Patent Watch: Rosetta gets allowance for gene expression signature

Agreements/contracts: Two companies will study mind-controlled prosthetics

Briefly noted

Product briefs

People in Places

MDD's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...